Trials / Sponsors / Brian Henick, MD
Brian Henick, MD
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Brodalumab in the Treatment of Immune-Related Adverse Events Breast Cancer, Esophageal Cancer, Kidney Cancer | Phase 1 | 2025-03-11 |
| Terminated | Liver Directed RT + Chemo-immunotherapy for ES-SCLC Small-cell Lung Cancer | Phase 2 | 2021-09-20 |